Rice Hall James & Associates, LLC Aclaris Therapeutics, Inc. Transaction History

Rice Hall James & Associates, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 30, 2019	SELL	$0.79 - $2.47 $404,147 - $1.26 Million	-511,579 Closed	0 $0
Q2 2019 Aug 01, 2019	SELL	$2.13 - $7.06 $399,860 - $1.33 Million	-187,728 Reduced 26.84%	511,579 $1.12 Million
Q1 2019 May 01, 2019	BUY	$5.63 - $7.84 $889,855 - $1.24 Million	158,056 Added 29.2%	699,307 $4.19 Million
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $952,900 - $2.33 Million	151,254 Added 38.78%	541,251 $4 Million
Q3 2018 Oct 25, 2018	SELL	$14.38 - $20.89 $134,381 - $195,217	-9,345 Reduced 2.34%	389,997 $5.66 Million
Q2 2018 Aug 02, 2018	BUY	$16.46 - $20.33 $3.09 Million - $3.81 Million	187,545 Added 88.55%	399,342 $7.98 Million
Q1 2018 Apr 25, 2018	BUY	$17.08 - $25.64 $2.49 Million - $3.74 Million	145,988 Added 221.84%	211,797 $3.71 Million
Q4 2017 Jan 23, 2018	BUY	$21.47 - $27.8 $522,257 - $676,235	24,325 Added 58.64%	65,809 $1.62 Million
Q3 2017 Oct 30, 2017	BUY	$23.02 - $28.8 $954,961 - $1.19 Million	41,484	41,484 $1.07 Million

52.4M

32.4K

3.3K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $139M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.